Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M571Revenue $M126Net Margin (%)9.3Altman Z-Score23.3
Enterprise Value $M537EPS $0.7Operating Margin %14.5Piotroski F-Score4
P/E(ttm)48.4Beneish M-Score-2.6Pre-tax Margin (%)14.5Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %16.4Current Ratio5.2Lower Leverage y-yY
Price/Free Cash Flow367y-y EBITDA Growth Rate %4.7ROA % (ttm)9.9Higher Current Ratio y-yN
Dividend Yield %--PEG3.0ROE % (ttm)11.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.3ROIC % (ttm)16.9Gross Margin Increase y-yN

Gurus Latest Trades with VASC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VASCJoel Greenblatt 2015-03-31 Sold Out -0.0019%$25.65 - $31.5
($28.71)
$ 33.0915%Sold Out0
VASCMario Gabelli 2015-03-31 Reduce$25.65 - $31.5
($28.71)
$ 33.0915%Reduce 2.27%249,571
VASCJoel Greenblatt 2014-12-31 Buy $23.74 - $30.54
($27.17)
$ 33.0922%New holding8,442
VASCJoel Greenblatt 2014-09-30 Sold Out -0.01%$21.87 - $25.07
($23.72)
$ 33.0940%Sold Out0
VASCJoel Greenblatt 2014-03-31 Buy 0.01%$22.99 - $26.92
($24.81)
$ 33.0933%New holding24,570
VASCJoel Greenblatt 2013-03-31 Sold Out -0.01%$14.4 - $16.71
($15.57)
$ 33.09113%Sold Out0
VASCJoel Greenblatt 2012-12-31 Buy 0.01%$13.32 - $15.35
($14.62)
$ 33.09126%New holding10,137
VASCMario Gabelli 2011-03-31 Reduce-0.01%$10.48 - $12.06
($11.04)
$ 33.09200%Reduce 32.85%397,196
VASCMario Gabelli 2010-09-30 Add0.01%$10.93 - $12.64
($11.83)
$ 33.09180%Add 41.04%600,796
VASCMario Gabelli 2010-06-30 Reduce-0.01%$9.05 - $13.04
($10.72)
$ 33.09209%Reduce 32.34%425,971
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VASC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROOT HOWARDCEO 2015-05-04Sell25,000$32.621.16view
POWERS CARRIEVP of Marketing 2015-04-27Sell6,000$34.9-5.44view
HENNEN JAMESSr. VP of Finance and CFO 2015-04-24Sell4,792$35.66-7.46view
O'CONNELL PAULDirector 2015-02-25Sell2,583$28.7114.94view
ERB JOHN LDirector 2015-02-18Sell10,000$28.5615.55view
POWERS CARRIEVP of Marketing 2015-02-10Sell15,794$26.8123.09view
RUTSTEIN WILLIAMSr. VP of International Sales 2015-02-10Sell10,814$26.9122.63view
ROOT HOWARDCEO 2015-02-09Sell25,000$28.5715.51view
HENNEN JAMESSr. VP of Finance and CFO 2015-02-05Sell11,301$27.6219.48view
SAUCEDO JORGEDirector 2015-02-05Sell10,000$27.3620.61view

Press Releases about VASC :

    Quarterly/Annual Reports about VASC:

    News about VASC:

    Articles On GuruFocus.com
    Vascular Solutions Inc. Reports Operating Results (10-K) Feb 01 2011 
    Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares Nov 04 2010 
    Vascular Solutions Inc. Reports Operating Results (10-K) Feb 02 2010 
    Vascular Solutions Inc. Reports Operating Results (10-Q) Apr 17 2009 
    Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call Tuesday, February 3, 2009 at 3:30 Jan 08 2009 

    More From Other Websites
    Zacks.com featured expert Kevin Matras highlights: SVB Financial Group, AMC Networks, Vascular... May 06 2015
    VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 04 2015
    Nasdaq stocks posting largest percentage increases Apr 29 2015
    Vascular Solutions To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference Apr 29 2015
    Vascular Solutions to Participate in Bank of America Merrill Lynch 2015 Health Care Conference Apr 29 2015
    Chemed Posts Stellar Q1; Beats on Earnings and Revenues - Analyst Blog Apr 29 2015
    Vascular Solutions Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape Apr 27 2015
    VASCULAR SOLUTIONS INC Financials Apr 25 2015
    10-Q for Vascular Solutions, Inc. Apr 23 2015
    Vascular Solutions discloses indicted CEO's pay and business risk Apr 22 2015
    VASCULAR SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Apr 22 2015
    Vascular Solutions posts 1Q profit Apr 21 2015
    Vascular Solutions posts 1Q profit Apr 21 2015
    Vascular Solutions Reports First Quarter Results Apr 21 2015
    VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 21 2015
    Vascular Solutions Reports First Quarter Results Apr 21 2015
    Q1 2015 Vascular Solutions Inc Earnings Release - After Market Close Apr 21 2015
    Vascular Solutions Announces Q1 Earnings Date Mar 31 2015
    Vascular Solutions, Inc. to Webcast First Quarter Conference Call Mar 31 2015
    Vascular Solutions Launches PolarCath™ Peripheral Dilatation System Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK